Sign in

CIK 0001662579

  • Non-accelerated filer
  • Smaller reporting company

C4 Therapeutics, Inc.

Sign in to watch
Ticker
CCCC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
475617627
Phone
+1 617-231-0700
Business address
490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
  1. 4 Grant or award Director acquired 3,516 shares (grant or award)
  2. 4 Grant or award Director acquired 4,298 shares (grant or award)
  3. 4 Grant or award Chief Scientific Officer acquired 26,000 shares (grant or award)
  4. 4 Grant or award Chief Legal Officer acquired 20,000 shares (grant or award)
  5. 4 Grant or award Chief Business Officer acquired 20,000 shares (grant or award)
  6. 4 Grant or award Chief People Officer acquired 20,000 shares (grant or award)
  7. 4 Grant or award Chief Financial Officer acquired 26,000 shares (grant or award)
  8. 4 Grant or award President & CEO acquired 81,600 shares (grant or award)
  9. 4 Open-market buy Director bought 5,667 shares at $5.60 ($31,735)
  10. 4 Shares withheld for taxes Chief Medical Officer gave up 1,301 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Financial Officer gave up 1,301 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chief Business Officer gave up 1,222 shares (to pay taxes)
  13. 4 Shares withheld for taxes President & CEO gave up 4,319 shares (to pay taxes)
  14. 4 Shares withheld for taxes Chief People Officer gave up 1,301 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Legal Officer gave up 1,301 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Scientific Officer gave up 1,301 shares (to pay taxes)
  17. 4 Option exercise Director acquired 712 shares (option exercise)
  18. 4 Grant or award Director acquired 1,568 shares (grant or award)
  19. 4 Grant or award Director acquired 1,763 shares (grant or award)
  20. 4 Grant or award Director acquired 1,725 shares (grant or award)

Page 8 of 15 · 296 filings